In an exclusive interview with physician and writer Dr. Jeremy Faust on Substack, Makary opened up about his first weeks on ...

Encompass Health tapped Patrick Tuer to serve as its first COO. He has held various leadership positions, including group ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The U.S. Transportation Department said Thursday it is taking steps to retain and recruit more air traffic controllers to ...

Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...

Gilead will pay $202 million to resolve claims that it paid kickbacks to healthcare providers in the form of honoraria, meals ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

A recall of seafood burgers by the Connecticut based company Caraluzzi's Markets has been issued a Class I risk ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

Read More: What Trump Has Done on Reproductive Health in His First 100 Days ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the ...